September 7, 2017 – Vancouver, B.C. – Alliance Growers Corp. (CSE: ACG; FWB: 1LA) (“Alliance Growers” or the “Company”) is pleased to announce that in connection with the acquisition of the land for the Cannabis Botany Centre, Alliance is finalizing an exclusive financing proposal with a Western European Financing group with offices in Amsterdam, New York, London and Germany.
The financing of Alliance Growers projects is being structured in stages as the capital is required, and not at one time to prevent unnecessary shareholder dilution. The exclusive financing will be carried out over time in the form of straight equity, convertible debt, streaming or debt financing in the amount of USD$5 Million to USD$10 Million based on the underlying projects, with the initial tranche between USD$500K and USD$1M, expected to take place in September 2017.
One of the key benefits of the engagement will be the introduction to strategic investors who are already involved in the cannabis space in Europe and South America. In addition to financing projects in Europe and North America, this group has been involved in financing projects in Brazil and Latin America for over 10 years.
Specifically, it has been agreed through several discussions that the capital will be secured to finance the Cannabis Botany Centre, strategic investments in ACMPR applicants (eg. CanWe Growers), investment in the Israeli Medical Cannabis company (to secure pharmaceutical grade CBD oil for international distribution) and the Cannabis Marketplace App. Other projects may be added to the agreement as they evolve.
Dennis Petke, Alliance Growers’ President and CEO, commented “We have all been waiting for this time in the life of Alliance Growers, where significant financing comes together with the acquisition of the land for the Cannabis Botany Centre and the commencement of the ACMPR application. This combination is the catalyst we have all been waiting for. I am certain all stakeholders agree with Alliance Growers management that getting our projects financed will catapult the Company to the next level and make Alliance Growers one of the best cannabis investment opportunities of 2017 andon. Company management must now roll up its sleeves and focus our efforts for the benefit of all shareholders.”
About Alliance Growers
Alliance Growers Corp. is a diversified cannabis company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Botany Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers is finalizing a new business partnership with Botanical Research In Motion Inc., to jointly develop and operate a 40,000 square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the “Chibafreen Invitro Plant Production System”, which assures consistent composition and purity of each plantlet for the growers.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer Applicants at various stages in the Health Canada License process.
If you would like to be added to Alliance Growers’ news distribution list, please send your email address to email@example.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
President and CEO
For more information contact:
Corporate Communications Consultant
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company’s corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company’s ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the Company’s ability to identify and complete additional suitable acquisitions to further the Company’s growth as well as risks associated with the medical marijuana industry in general, such as operational risks in development and production delays or changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.